CS logo
small CS logo
Johns Hopkins University Drug Development Unit

Baltimore, Maryland, United States

About Johns Hopkins University Drug Development Unit


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Johns Hopkins University Drug Development Unit


During the past decade, Johns Hopkins University Drug Development Unit conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins University Drug Development Unit" #1 collaborator was "amfAR, The Foundation for AIDS Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Johns Hopkins University Drug Development Unit


According to Clinical.Site data, the most researched conditions in "Johns Hopkins University Drug Development Unit" are "HIV Prevention" (1 trials) and "Human Immunodeficiency Virus (HIV)" (1 trials). Many other conditions were trialed in "Johns Hopkins University Drug Development Unit" in a lesser frequency.

Clinical Trials Intervention Types at Johns Hopkins University Drug Development Unit


Most popular intervention types in "Johns Hopkins University Drug Development Unit" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Radiolabeled Normosol-R" (1 trials), "Radiolabeled autologous seminal fluid" (1 trials) and "Tenofovir Disoproxil Fumarate/Emtricitabine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Johns Hopkins University Drug Development Unit


The vast majority of trials in "Johns Hopkins University Drug Development Unit" are 1 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Johns Hopkins University Drug Development Unit


Currently, there are NaN active trials in "Johns Hopkins University Drug Development Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Johns Hopkins University Drug Development Unit, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Johns Hopkins University Drug Development Unit, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".